ENDRA Life Sciences's EBIT per Share for the
three
months ended in Dec. 2023 was $-0.17.
Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $-2.00.
During the past 3 years, the average EBIT per Share Growth Rate was 48.30% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 46.80% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for ENDRA Life Sciences's EBIT per Share or its related term are showing as below:
NDRA'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: 6.3 Med: 29 Max: 48.3
Current: 48.3
During the past 10 years, the highest 3-Year average EBIT per Share Growth Rate of ENDRA Life Sciences was 48.30% per year. The lowest was 6.30% per year. And the median was 29.00% per year.
NDRA's 3-Year EBIT Growth Rate is ranked better than 92.09% of 177
companies
in the Medical Diagnostics & Research industry
Industry Median: -1.7
vs NDRA: 48.30
ENDRA Life Sciences EBIT per Share Historical Data
The historical data trend for ENDRA Life Sciences's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.00
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ENDRA Life Sciences (NAS:NDRA) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
ENDRA Life Sciences EBIT per Share Related Terms
Thank you for viewing the detailed overview of ENDRA Life Sciences's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
ENDRA Life Sciences (ENDRA Life Sciences) Business Description
ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI but at 1/50th the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NDRA has been successfully added to your 